ASH Conference Coverage
Featured Articles
(Markets Insider) Dec 12, 2017 - Servier, Pfizer Inc. and Cellectis presented at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta preliminary results from two phase 1 studies of UCART19, an investigational allogeneic anti-CD19 CAR T-cell product, in adult and pediatric patients with relapsed or...
Read Article
(ASH 2017) Dec 12, 2017 - In four clinical trials being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers report promising results suggesting patients with blood disorders and several types of cancer will soon have significantly expanded options for treatment.
Read Article
Latest Articles
December 19, 2017
December 14, 2017
December 14, 2017
December 14, 2017
December 13, 2017
December 13, 2017
December 13, 2017
December 13, 2017
View More
News Commentary
There is no ASH Conference Coverage commentary.

OBR Blog
By Lynne Lederman, PhD At this past December’s American Society of Hematology (ASH) annual meeting, the late-breaking... Read more
January 17, 2017
Introduction Presenting you with timely market feedback from the 58th ASH Annual Meeting held in December 2016, OBR and... Read more
January 17, 2017